Its subscription plans start at $8 per test for a 12-month commitment, with flexible options available. The startup’s Cortisol Hormometer falls under general wellness guidelines, while its ...

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long ...

Beyond current successes, Eli Lilly is innovating with a potential game-changing oral GLP-1, orforglipron. Read why I ...

Eli Lilly LLY -0.47% agreed to acquire Verve Therapeutics VERV 0.45% for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio. Under the agreement ...

The cuts slash the CDC's budget from nearly $9.2 billion in FY 2024 to $4.2 billion. At least 20%, or $1 billion, of the funding cut is moving to AHA. The cuts will have a trickle-down effect on ...

What You Need To Know Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay when they fill prescriptions The moves promise ...

A new study has shown that mangoes reduce blood pressure and cholesterol levels significantly in postmenopausal women, with potential heart health benefits.